ANALGESICS

Clinical trials for ANALGESICS explained in plain language.

Never miss a new study

Get alerted when new ANALGESICS trials appear

Sign up with your email to follow new studies for ANALGESICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1 Terminated 1

Placenta cells tested as COVID fighter – but trial stopped early

Disease control Terminated

This early-phase trial tested a new therapy called CYNK-001, which uses natural killer cells from the placenta to fight COVID-19. It enrolled only 7 adults with moderate COVID-19. The study was terminated early, so we have limited information on safety and effectiveness.

Matched conditions: ANALGESICS

Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control

Last updated Jun 28, 2026 00:00 UTC

ANALGESICS

Get alerted when new ANALGESICS trials appear

Placenta cells tested as COVID fighter – but trial stopped early